Diet and Weight Reducing Centers

The 1,400 diet and weight reducing centers in the US help individuals attain or maintain a desired weight using non-medical methods. Weight loss services account for the majority of industry sales. Firms may also sell weight reduction products, such as food supplements or prepared food products.

High Customer Failure Rate

Most consumers fail to achieve or maintain weight loss through traditional programs.

Competition from Alternative Service Providers

Diet and weight reducing centers compete with a range of alternative service providers, including health care providers, fitness centers, pharmaceuticals, self-help programs, and surgical procedures.

Sep 1, 2026 - Weight Watchers Results Highlight GLP-1 Shift

• Weight Watchers’ Q2 2026 results point to a US diet and weight loss program industry increasingly shifting from traditional behavioral plans toward higher-value clinical and GLP-1-supported offerings. WW’s Core+ subscribers rose 13.9% year over year, while clinical subscribers increased 55.7% and clinical revenue grew 30.4%. By contrast, total behavioral subscribers fell 24.6%, with weakness concentrated in the basic Core tier. The results suggest consumers are willing to pay more for integrated programs combining medication, coaching, nutrition, and behavioral support, even as demand for lower-cost standalone programs declines. Clinical services generated 24.6% of Q2 revenue, up from 15.9% for full-year 2025. WW expects Core+ growth to continue and clinical revenue to reach 25%-30% of 2026 sales, supporting a favorable outlook for medically integrated weight loss providers.
• Consumer confidence weakened in August 2026, signaling a more cautious outlook for US diet and weight loss programs, where spending can be discretionary. The University of Michigan’s Index of Consumer Sentiment fell 6.3% from July to 51.7 and 11.2% from August 2025. Its Current Economic Conditions Index declined 5.3% month over month to 51.9, while the Consumer Expectations Index dropped 7.0% to 51.5, suggesting consumers may be more selective about program fees and related purchases. The Conference Board’s Consumer Confidence Index slipped 0.8 points from July to 89.4 in August. Its Present Situation Index improved 6.8 points to 121.2, but the Expectations Index fell 5.8 points to 68.2. Together, the results suggest near-term spending may remain relatively stable, while weaker expectations could restrain longer-term commitments to paid weight loss programs.
• WeightWatchers' new partnership with Eli Lilly's LillyDirect reflects the US diet and weight-loss industry's continued shift toward medically supervised obesity care, according to Yahoo Finance. LillyDirect is Eli Lilly's digital healthcare platform that helps eligible patients access obesity treatment, including the weight-loss drug Zepbound (tirzepatide), through independent healthcare providers, prescription fulfillment, and educational resources. By integrating WeightWatchers Med+ into the platform, patients can pair GLP-1 medication with physician oversight, nutrition guidance, behavioral coaching, lifestyle support, and the company's GLP-1 Success program. For the broader industry, the partnership highlights growing demand for integrated care models that combine medication with long-term clinical and behavioral support, increasing competitive pressure on traditional weight-loss providers to expand medical services and form partnerships with healthcare organizations.
• Medifast’s second-quarter results point to a challenging but evolving outlook for the industry as weight loss drugs continue to disrupt traditional programs. Medifast revenue fell 27.6% to $76.4 million, while active earning coaches declined 48.7%, with management directly attributing part of the weakness to rapid GLP-1 adoption. At the same time, revenue per active coach rose 41%, suggesting consumers still value structured nutrition and personalized guidance. The broader industry is likely to shift away from stand-alone weight-loss programs toward more comprehensive metabolic-health offerings that complement medication, emphasize body composition and lifestyle change, and support consumers during and after GLP-1 use. Near-term pressure remains significant, but hybrid models combining medication, nutrition, coaching, and metabolic health services may offer stronger growth opportunities.

Industry size & Structure

The average diet or weight reducing company operates out of a single location, employs about 10 workers and generates $1.2 million annually.

• The diet and weight reducing services industry consists of about 1,400 firms that employ about 14,000 workers and generates $1.7 billion annually.
• Franchises account for half of the industry. Franchisees account for 21% of establishments.
• The industry is highly concentrated; the top 50 companies account for 76% of industry revenue.
• Large firms, which include WW (Weight Watchers), Nutrisystem and Jenny Craig (both owned by Wellful), and Medifast, may have international operations.